Axa S.A. Repligen Corp Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $26,129 - $31,888
153 Added 5.02%
3,201 $588,000
Q4 2023

Jul 16, 2024
SELL
$114.17 - $185.35 $17,468 - $28,358
-153 Reduced 4.78%
3,048 $548,000
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $347,990 - $564,946
3,048 New
3,048 $548,000
Q4 2022

Feb 14, 2023
SELL
$162.42 - $220.56 $2.63 Million - $3.57 Million
-16,200 Closed
0 $0
Q3 2022

Feb 14, 2023
SELL
$160.42 - $256.21 $2.95 Million - $4.71 Million
-18,400 Reduced 53.18%
16,200 $3.03 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $2.6 Million - $4.15 Million
16,200 New
16,200 $3.03 Million
Q2 2022

Aug 15, 2022
SELL
$140.68 - $188.02 $4.87 Million - $6.51 Million
-34,600 Closed
0 $0
Q1 2022

Feb 14, 2023
BUY
$161.19 - $257.96 $2.97 Million - $4.75 Million
18,400 Added 113.58%
34,600 $6.51 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $386,856 - $619,104
-2,400 Reduced 6.49%
34,600 $6.51 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $742,770 - $913,410
3,000 Added 8.82%
37,000 $9.8 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $1.34 Million - $2.24 Million
-6,900 Reduced 16.87%
34,000 $9.83 Million
Q2 2021

Aug 13, 2021
BUY
$165.87 - $220.95 $2.41 Million - $3.2 Million
14,500 Added 54.92%
40,900 $8.16 Million
Q1 2021

May 14, 2021
SELL
$180.37 - $226.26 $1.41 Million - $1.76 Million
-7,800 Reduced 22.81%
26,400 $5.13 Million
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $207,312 - $289,198
1,400 Added 4.27%
34,200 $6.55 Million
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $428,785 - $553,945
-3,500 Reduced 9.64%
32,800 $4.84 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $2.16 Million - $3.22 Million
22,900 Added 170.9%
36,300 $4.49 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $1.14 Million - $1.46 Million
13,400 New
13,400 $1.29 Million
Q4 2019

Feb 18, 2020
SELL
$73.84 - $93.08 $413,504 - $521,248
-5,600 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $429,240 - $534,856
5,600 New
5,600 $429,000
Q2 2019

Aug 13, 2019
SELL
$54.2 - $85.95 $238,480 - $378,180
-4,400 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$49.45 - $62.8 $202,745 - $257,480
-4,100 Reduced 48.24%
4,400 $260,000
Q4 2018

Feb 13, 2019
BUY
$48.26 - $68.88 $410,210 - $585,480
8,500 New
8,500 $448,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email